World Journal of Clinical Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Welcome to the World Journal of Clinical Oncology

Indoleamine 2,3-dioxygenase inhibition as potential immunotherapeutic strategy for breast cancer.

Pulse structure.

Mobilization algorithms.

Multiple roles of miRNAs during development of esophageal squamous cell carcinoma.

BRCA, PARP-inhibitors and synthetic lethality in gastrointestinal cancers.

‹ ›

Features of primary pancreatic lymphoma: A bi-institutional review with an emphasis on typical and atypical imaging features

Featured Articles More >>

Features of primary pancreatic lymphoma: A bi-institutional ... 2021-09-24
Real world evidence on first and second line palliative chem... 2021-09-24
Re-irradiation for high-grade gliomas: Has anything changed? 2021-09-24
Metastatic disease to the liver: Locoregional therapy strate... 2021-09-24
Embracing cancer immunotherapy with vital micronutrients 2021-09-24

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 737440

Number of visits today: 105

Number of downloads: 288705

MEMBERSHIP

BPG JOURNALS

GUIDELINES FOR AUTHORS

World Journal of Clinical Oncology (WJCO, World J Clin Oncol) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group. WJCO accepts both solicited and unsolicited manuscripts. Articles published in WJCO are high-quality, basic and clinical, influential research articles by established academic authors as well as new researchers. The paramount objective of WJCO is to showcase and promote distinguished research in the field of oncology, to help advance development of this field. The types of articles published in WJCO include Editorial, Opinion Review, Frontier, Review, Minireview, Basic Study, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. Submit here >>

2021 Published Issues

9 8 7 6 5 4 3 2 1

Editors-in-Chief

Hiten RH Patel, BM BCh, BSc, FRCS, PhD, Professor, Surgical Oncologist, (E-mail: hrhpatel@hotmail.com) Department of Urology, University Hospital North Norway (UNN), Tromso 9038, Norway
Stephen Safe, PhD, Professor, (E-mail: ssafe@cvm.tamu.edu) Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77845, United States

Indexing/Abstracting

The WJCO is now abstracted and indexed in PubMed, PubMed Central, Emerging Sources Citation Index (Web of Science), China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and Superstar Journals Database.

Journal Metrics

The 2021 edition of Journal Citation Reports^® cites the 2020 Journal Citation Indicator (JCI) for WJCO as 0.48.

ISSN

2218-4333 (online)

Current Issue

Other Issues: Previous | Next | Latest | Archive | Issue 9 (3)

Contents Volume 12 Issue 9 September 24, 2021

Review

Embracing cancer immunotherapy with vital micronutrients

Raymond C-F Yuen, Shiu-Ying Tsao

World J Clin Oncol 12(9):712-724. Published online Sep 24, 2021. doi: 10.5306/wjco.v12.i9.712

(2) | Open

Metastatic disease to the liver: Locoregional therapy strategies and outcomes

Kylie E Zane, Jordan M Cloyd, Khalid S Mumtaz, Vibhor Wadhwa, Mina S Makary

World J Clin Oncol 12(9):725-745. Published online Sep 24, 2021. doi: 10.5306/wjco.v12.i9.725

(0) | Open

Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy: A focus on relapsed/refractory germ cell tumors

Eleni Porfyriou, Sylvia Letsa, Christos Kosmas

World J Clin Oncol 12(9):746-766. Published online Sep 24, 2021. doi: 10.5306/wjco.v12.i9.746

(0) | Open

Re-irradiation for high-grade gliomas: Has anything changed?

Sonia García-Cabezas, Eleonor Rivin del Campo, Juan Solivera-Vela, Amalia Palacios-Eito

World J Clin Oncol 12(9):767-786. Published online Sep 24, 2021. doi: 10.5306/wjco.v12.i9.767

(0) | Open

Minireviews

Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer

Hakon Blomstrand, Atul Batra, Winson Y Cheung, Nils Oskar Elander

World J Clin Oncol 12(9):787-799. Published online Sep 24, 2021. doi: 10.5306/wjco.v12.i9.787

(0) | Open

Retrospective Cohort Study

Long-term results of the treatment of Hodgkin’s lymphoma in a resource-constrained setting: Real-world data from a single center

Luisa Fernanda Sánchez-Valledor, Thomas M Habermann, Iván Murrieta-Alvarez, Alejandra Carmina Córdova-Ramírez, Montserrat Rivera-Álvarez, Andrés León-Peña, Yahveth Cantero-Fortiz, Juan Carlos Olivares-Gazca, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Argüelles

World J Clin Oncol 12(9):800-807. Published online Sep 24, 2021. doi: 10.5306/wjco.v12.i9.800

(0) | Open

Retrospective Study

Role of mammogram and ultrasound imaging in predicting breast cancer subtypes in screening and symptomatic patients

Tay Wei Ming Ian, Ern Yu Tan, Niketa Chotai

World J Clin Oncol 12(9):808-822. Published online Sep 24, 2021. doi: 10.5306/wjco.v12.i9.808

(0) | Open

Features of primary pancreatic lymphoma: A bi-institutional review with an emphasis on typical and atypical imaging features

Nicole Segaran, Kumaresan Sandrasegaran, Catherine Devine, Mindy X Wang, Chintan Shah, Dhakshinamoorthy Ganeshan

World J Clin Oncol 12(9):823-832. Published online Sep 24, 2021. doi: 10.5306/wjco.v12.i9.823

(0) | Open